University of Luebeck
uni-luebeck.deTotal trials
75
Active
13
Phase 3
3
Total enrollment
52,296
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Semaglutide | — | — | — | — | — | 1 | |
| autologous PRP | — | — | — | — | — | 1 | |
| Follitropin delta | — | — | — | — | — | 1 |
Next readouts
- 2025-04-30
- 2026-03
- 2029-04
Top conditions
- Atrial Fibrillation6
- Infertility4
- Heart Failure3
- Coronary Artery Disease3
- Pregnancy3
- Acute Myocardial Infarction3
- Atrial Fibrillation (AF)2
- Spatial Neglect2
Frequently asked questions about University of Luebeck
- How many clinical trials does University of Luebeck have on ClinicalTrials.gov?
- University of Luebeck is listed as the lead sponsor on 75 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Luebeck's trials are in Phase 3?
- 3 of University of Luebeck's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does University of Luebeck focus on?
- University of Luebeck's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, Infertility, Heart Failure, Coronary Artery Disease, Pregnancy.
- When are University of Luebeck's next clinical trial readouts?
- University of Luebeck has 3 upcoming primary-completion readouts tracked here; the soonest is “Ovarian PRP (Platelet Rich Plasma) Injection for Follicular Activation”, expected around 2025-04-30.